Clozapine Related Clinical Trials
A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-Resistant Schizophrenia [Active, not recruiting]
Treat Clozapine-Resistant Schizophrenia Comparing Between Clozapine + Haloperidol Versus Clozapine + Electroconvulsive Therapy (ECT) [Recruiting]
FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey [Completed]
Clozapine Versus Amisulpride in Treatment-resistant Schizophrenia Patients [Recruiting]
Clozapine for Cannabis Use in Schizophrenia [Not yet recruiting]
A Long Term Study of Clozapine in Patients With Treatment-Resistant Schizophrenia [Active, not recruiting]
Alcoholism and Schizophrenia: Effects of Clozapine [Terminated]
Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder [Recruiting]
Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia [Terminated]
F-18 Altanserin PET Study of Patients Receiving Clozapine [Recruiting]
Treating Clozapine-induced Sinustachycardia With Bisoprolol [Recruiting]
Clozapine IM and Aggression in Schizophrenic Patients [Not yet recruiting]
First Episode Schizophrenia and Cannabis-Related Disorder Study [Recruiting]
The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia [Recruiting]
Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia [Completed]
Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia [Terminated]
Clozapine Versus Haloperidol for Treating the First Episode of Schizophrenia [Terminated]
Effectiveness of Clozapine Versus Olanzapine for Treatment-Resistant Schizophrenia [Terminated]
Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents [Completed]
Association of Multiple Genetic Polymorphisms With Clozapine-Associated Metabolic Change in Schizophrenia [Recruiting]
Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine [Recruiting]
Clozapine for Treatment-Resistant Mania [Completed]
Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis [Recruiting]
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs [Completed]
Serum Clozapine and Cognition [Recruiting]
Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ) [Recruiting]
Effects of Adjunctive Metformin on Metabolic Profiles in Clozapine-treated Schizophrenic Patients [Recruiting]
Adjunctive Minocycline in Clozapine Treated Schizophrenia Patients [Recruiting]
Vitamin D for Schizophrenia [Not yet recruiting]
Efficacy of Pimozide Augmentation for Clozapine Partial Response [Recruiting]
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder [Recruiting]
Amisulpride Augmentation in Clozapine-unresponsive Schizophrenia [Not yet recruiting]
Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual [Recruiting]
Comparison of Clozapine or Olanzapine in Childhood-Onset Psychotic Disorders [Active, not recruiting]
Olanzapine Versus Clozapine in Treatment Refractory Schizophrenia [Completed]
The Effect of Metformin on Obesity and Metabolic Disturbance in Patients Taking Clozapine [Recruiting]
Clozapine and Risperidone for Treatment of First Episode Schizophrenia and Cannabis Use Disorder [Suspended]
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia [Recruiting]
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia [Recruiting]
Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia [Recruiting]
Polypharmacy in Clozapine-Resistant Schizophrenia [Recruiting]
Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial [Completed]
Clozapine to Reduce Marijuana Use in Schizophrenic Individuals [Recruiting]
A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia [Completed]
Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease [Active, not recruiting]
Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine [Recruiting]
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia [Active, not recruiting]
Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus [Completed]
Augmenting Clozapine With Sertindole - SERCLOZ [Recruiting]
Benzamide Derivates as Treatment of Clozapine-Induced Hypersalivation [Not yet recruiting]
Effects of Gene Polymorphisms on Metabolic Features in Clozapine-treated Patients With Schizophrenia [Recruiting]
Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide [Recruiting]
Metabolic Side-effects for Second-generation Antipsychotics [Recruiting]
Rosiglitazone for Clozapine Induced Glucose Metabolism Impairment [Active, not recruiting]
A Placebo-Controlled Trial Ampakine Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia [Completed]
Optimization of Treatment and Management of Schizophrenia in Europe [Recruiting]
Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients [Completed]
An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308 AM1) [Not yet recruiting]
Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia [Recruiting]
Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia [Not yet recruiting]
Risperidone Augmentation [Completed]
Glycine and D-Cycloserine in Schizophrenia [Completed]
Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay [Completed]
CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia [Completed]
A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients [Completed]
Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine [Recruiting]
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia [Completed]
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis [Recruiting]
A Study of Strategies to Improve Schizophrenia Treatment [Completed]
CATIE- Schizophrenia Trial [Completed]
Treating Drug-Resistant Childhood Schizophrenia [Recruiting]
Antipsychotic Polypharmacy in Schizophrenia [Recruiting]
Evaluation of Clonazepam and Paroxetine for Panic Disorder With Depression [Completed]
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia [Recruiting]
Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Chronic Residual Schizophrenia [Recruiting]
Study With IT-Aided Preventive Program in Schizophrenia [Not yet recruiting]
Glucose and Lipid Metabolism on Antipsychotic Medication [Recruiting]
fMRI Cholinergic Mechanisms in Schizophrenia [Recruiting]
Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics
Improving Outcome in Schizophrenia Through Identification of Genetic Risk Factors [Recruiting]
FMRI of Cholinergic Mechanisms in Schizophrenia [Not yet recruiting]
Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)? [Recruiting]
The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients [Completed]
Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients [Completed]
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine [Recruiting]
Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism [Recruiting]
|